Tikun Therapeutics

www.tikuntherapeutics.com
c/o The Dysautonomia Foundation
315 W. 39th Street Suite 701
New York, NY 10018

Company Info

Phone
(212) 279-1066

Year Established
2017

Contacts

Adam Sachs
President & CEO

Company Description

Tikun Therapeutics is an early-stage Public Benefit Corporation (PBC) wholly owned by the Familial Dysautonomia Foundation, supported by both grants and donations and focused on driving drug development for the ultra rare and progressive genetic disease familial dysautonomia (FD).